Insight Molecular Diagnostics Inc. (IMDX): Shareholders' Equity
-$31.46M
As of 2025-12-31
-$21.30M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$31.46M | n/m | 2026-03-26, Balance as of period end |
| 2024-12-31 | -$12.27M | n/m | 2026-03-26, Balance as of period end |
| 2023-12-31 | $20.47M | -40.3% | 2025-03-24, Balance as of period end |
| 2022-12-31 | $34.29M | -47.4% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $65.22M | +94.8% | 2023-04-12, Balance as of period end |
| 2020-12-31 | $33.48M | +8.6% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $30.84M | +800.9% | 2021-03-19, Balance as of period end |
| 2018-12-31 | $3.42M | -22.3% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $4.40M | -55.4% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $9.86M | -5.3% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $10.42M | n/m | 2018-04-02, Balance as of period end |
| 2014-12-31 | -$1.07M | n/a | 2017-02-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$31.46M | n/m |
| Biomerica Inc (BMRA) | 2026-05-31 | $2.63M | -35.9% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $30.16M | +75.4% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$6.93M | n/m |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$34.25M | n/m |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | $527.16M | -29.4% |
| Immucell Corp (ICCC) | 2025-12-31 | $27.06M | -1.7% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $68.78M | -16.5% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $671.39M | -23.0% |
Compare IMDX, BMRA, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗